Using serum amyloid A to screen dairy cows for sub-clinical inflammation.

In this study, 232 lactating dairy cows from six herds were observed for clinical signs of inflammation and simultaneously had blood samples drawn to determine whether or not Serum Amyloid A (SAA) was present. Serum protein electrophoresis and white blood cell differential count revealed inflammation in SAA+ samples but not in SAA-samples. Using positive SAA test results as the standard for presence of inflammation, clinical findings consistent with inflammation concurred with positive SAA results only 26% of the time (p<.001) while the lack of clinical signs consistent with inflammation concurred with negative SAA results 95% of the time (p<.001). There was also a significant difference (p<.005) in management styles in that cows permanently fed on wilted/cured forages and kept inside had a 26% prevalence of positive SAA blood samples whereas the overall prevalence of SAA+ samples was 16%. These findings indicate that whole herd screening using SAA can be of value to the veterinarian in helping to identify cows with inflammatory diseases. From a public health perspective, SAA testing of cows going to market can help differentiate those not needing intensive inspection from those that do.